Artiva Biotherapeutics (ARTV) Current Assets (2023 - 2025)
Historic Current Assets for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $129.5 million.
- Artiva Biotherapeutics' Current Assets fell 1397.47% to $129.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.5 million, marking a year-over-year decrease of 1397.47%. This contributed to the annual value of $188.6 million for FY2024, which is 13631.75% up from last year.
- Latest data reveals that Artiva Biotherapeutics reported Current Assets of $129.5 million as of Q3 2025, which was down 1397.47% from $149.1 million recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Current Assets registered a high of $188.6 million during Q4 2024, and its lowest value of $49.7 million during Q2 2024.
- In the last 3 years, Artiva Biotherapeutics' Current Assets had a median value of $149.1 million in 2025 and averaged $131.1 million.
- Over the last 5 years, Artiva Biotherapeutics' Current Assets had its largest YoY gain of 19963.62% in 2025, and its largest YoY loss of 1397.47% in 2025.
- Quarter analysis of 3 years shows Artiva Biotherapeutics' Current Assets stood at $79.8 million in 2023, then surged by 136.32% to $188.6 million in 2024, then plummeted by 31.33% to $129.5 million in 2025.
- Its Current Assets stands at $129.5 million for Q3 2025, versus $149.1 million for Q2 2025 and $170.0 million for Q1 2025.